CLEANSPARK, INC.·4

Mar 24, 8:16 PM ET

Monnig Taylor 4

Research Summary

AI-generated summary

Updated

CleanSpark (CLSK) CTO Monnig Taylor Receives Stock Awards

What Happened

  • Monnig Taylor, CleanSpark's Chief Technology Officer and Chief Operating Officer, was granted three derivative awards on March 20, 2026 totaling 1,320,500 share-equivalents (280,000; 210,000; and 830,500). Each grant is reported at $0.00 per share (award/derivative grants), meaning these are compensation awards (options/RSUs/LTIP/STPA) subject to vesting and performance conditions rather than open‑market purchases.

Key Details

  • Transaction date: March 20, 2026; Form 4 filed March 24, 2026 (filing appears timely).
  • Reported price: $0.00 per share (award/grant, transaction code A).
  • Total awarded: 1,320,500 share-equivalents (280,000 + 210,000 + 830,500).
  • Shares owned after transaction: Not provided in the supplied extract — see the full Form 4 for total beneficial ownership.
  • Notable vesting/performance terms (from footnotes):
    • Some awards are stock options that vest over time (e.g., equal annual installments over 3 years; monthly installments over 36 months).
    • Several awards are restricted stock units (RSUs) with time-based vesting dates through 2029.
    • Certain awards are performance‑contingent (LTIP/STPA): vesting may depend on stock price targets (e.g., $18.80 average by 3/20/2027; STPA targets $47–$94 before 9/30/2030) and operational metrics tied to leased power or RFS (e.g., MW or GW thresholds). Some awards only vest if the Reporting Person remains employed through the applicable vesting dates.
  • No indication in the provided extract of a 10b5-1 plan, tax withholding sale (F code), or late filing.

Context

  • These are compensation awards (options and RSUs) rather than purchases; they represent potential future economic interest if vesting/performance conditions are met. Such grants are common for executives as retention and performance incentives and do not, by themselves, signal an immediate buy or sell decision by the insider. For full details on vesting schedules, performance hurdles, and total beneficial ownership, review the complete Form 4 filing (Accession No. 0001193125-26-122453).